HM02260 | FBXO31 | prostate | MESH:D056486 | Drug-Induced Liver Injury | |
HM02260 | FBXO31 | prostate | MESH:D008171 | Lung Diseases | |
HM02260 | FBXO31 | prostate | MESH:D000799 | Angioedema | skin |
HM02260 | FBXO31 | prostate | MESH:D019465 | Craniofacial Abnormalities | |
HM02260 | FBXO31 | prostate | MESH:D008113 | Liver Neoplasms | |
HM02260 | FBXO31 | prostate | MESH:D008113 | Liver Neoplasms | |
HM02260 | FBXO31 | prostate | MESH:D002294 | Carcinoma, Squamous Cell | lung |
HM02260 | FBXO31 | prostate | MESH:D002294 | Carcinoma, Squamous Cell | liver |
HM02260 | FBXO31 | prostate | MESH:D002294 | Carcinoma, Squamous Cell | larynx |
HM02260 | FBXO31 | prostate | MESH:D002294 | Carcinoma, Squamous Cell | kidney |
HM02260 | FBXO31 | prostate | MESH:D002294 | Carcinoma, Squamous Cell | eye |
HM02260 | FBXO31 | prostate | MESH:D007249 | Inflammation | |
HM02260 | FBXO31 | prostate | MESH:D001321 | Autistic Disorder | |
HM02260 | FBXO31 | prostate | MESH:D004487 | Edema | |
HM02260 | FBXO31 | prostate | MESH:D004832 | Epilepsy, Absence | muscle |
HM02260 | FBXO31 | prostate | MESH:D017114 | Liver Failure, Acute | |
HM02260 | FBXO31 | prostate | MESH:D004938 | Esophageal Neoplasms | |
HM02260 | FBXO31 | prostate | MESH:D006548 | Hernia, Diaphragmatic | |
HM02260 | FBXO31 | prostate | MESH:D008107 | Liver Diseases | skin |
HM02260 | FBXO31 | prostate | MESH:D008107 | Liver Diseases | muscle |
HM02260 | FBXO31 | prostate | MESH:D008107 | Liver Diseases | lung |
HM02260 | FBXO31 | prostate | MESH:D008107 | Liver Diseases | liver |
HM02260 | FBXO31 | prostate | MESH:D000014 | Abnormalities, Drug-Induced | |
HM02260 | FBXO31 | prostate | MESH:D009062 | Mouth Neoplasms | |
HM02260 | FBXO31 | prostate | MESH:D017029 | Epilepsy, Complex Partial | muscle |
HM02260 | FBXO31 | prostate | MESH:D007333 | Insulin Resistance | |
HM02260 | FBXO31 | prostate | MESH:D020191 | Myoclonic Epilepsies, Progressive | nerve |
HM02260 | FBXO31 | prostate | MESH:D020191 | Myoclonic Epilepsies, Progressive | muscle |
HM02260 | FBXO31 | prostate | MESH:D008546 | Melanoma, Experimental | |
HM02260 | FBXO31 | prostate | MESH:D009135 | Muscular Diseases | muscle |
HM02260 | FBXO31 | prostate | MESH:D020521 | Stroke | blood vessel |
HM02260 | FBXO31 | prostate | MESH:D001749 | Urinary Bladder Neoplasms | ureter |
HM02260 | FBXO31 | prostate | MESH:D001749 | Urinary Bladder Neoplasms | bladder |
HM02260 | FBXO31 | prostate | MESH:D019310 | Pseudolymphoma | |
HM02260 | FBXO31 | prostate | MESH:D003294 | Seizures, Febrile | |
HM02260 | FBXO31 | prostate | MESH:D007674 | Kidney Diseases | ureter |
HM02260 | FBXO31 | prostate | MESH:D007674 | Kidney Diseases | pituitary |
HM02260 | FBXO31 | prostate | MESH:D007674 | Kidney Diseases | kidney |
HM02260 | FBXO31 | prostate | MESH:D008106 | Liver Cirrhosis, Experimental | |
HM02260 | FBXO31 | prostate | MESH:D006528 | Carcinoma, Hepatocellular | liver |
HM02260 | FBXO31 | prostate | MESH:D002252 | Carbon Tetrachloride Poisoning | |
HM02260 | FBXO31 | prostate | MESH:D019584 | Hot Flashes | |
HM02260 | FBXO31 | prostate | MESH:D002493 | Central Nervous System Diseases | spinal cord |
HM02260 | FBXO31 | prostate | MESH:D002493 | Central Nervous System Diseases | skin |
HM02260 | FBXO31 | prostate | MESH:D002493 | Central Nervous System Diseases | nerve |
HM02260 | FBXO31 | prostate | MESH:D002493 | Central Nervous System Diseases | muscle |
HM02260 | FBXO31 | prostate | MESH:D002493 | Central Nervous System Diseases | eye |
HM02260 | FBXO31 | prostate | MESH:D002493 | Central Nervous System Diseases | brain |
HM02260 | FBXO31 | prostate | MESH:D006333 | Heart Failure | heart |
HM02260 | FBXO31 | prostate | MESH:D015427 | Reperfusion Injury | |
HM02260 | FBXO31 | prostate | MESH:D012640 | Seizures | muscle |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | uterus |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | uterus |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | thyroid |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | skin |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | parathyroid gland |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | liver |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | kidney |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | eye |
HM02260 | FBXO31 | prostate | MESH:D000230 | Adenocarcinoma | adrenal gland |
HM02260 | FBXO31 | prostate | MESH:D004421 | Dystonia | |
HM02260 | FBXO31 | prostate | MESH:D004831 | Epilepsies, Myoclonic | muscle |
HM02260 | FBXO31 | prostate | MESH:D009765 | Obesity | |
HM02260 | FBXO31 | prostate | MESH:D008175 | Lung Neoplasms | lung |
HM02260 | FBXO31 | prostate | MESH:D010190 | Pancreatic Neoplasms | pancreas |
HM02260 | FBXO31 | prostate | MESH:D001778 | Blood Coagulation Disorders | bone marrow |
HM02260 | FBXO31 | prostate | MESH:D009203 | Myocardial Infarction | heart |
HM02260 | FBXO31 | prostate | MESH:D009369 | Neoplasms | spleen |
HM02260 | FBXO31 | prostate | MESH:D009369 | Neoplasms | bone marrow |
HM02260 | FBXO31 | prostate | MESH:D050171 | Dyslipidemias | |
HM02260 | FBXO31 | prostate | MESH:D004830 | Epilepsy, Tonic-Clonic | muscle |
HM02260 | FBXO31 | prostate | MESH:D010146 | Pain | |
HM02260 | FBXO31 | prostate | MESH:D013274 | Stomach Neoplasms | |
HM02260 | FBXO31 | prostate | MESH:D006330 | Heart Defects, Congenital | |
HM02260 | FBXO31 | prostate | MESH:D001161 | Arteriosclerosis | blood vessel |
HM02260 | FBXO31 | prostate | MESH:D019636 | Neurodegenerative Diseases | nerve |
HM02260 | FBXO31 | prostate | MESH:D018248 | Adenoma, Liver Cell | |
HM02260 | FBXO31 | prostate | MESH:D004827 | Epilepsy | muscle |
HM02260 | FBXO31 | prostate | MESH:D008103 | Liver Cirrhosis | liver |
HM02260 | FBXO31 | prostate | MESH:D015428 | Myocardial Reperfusion Injury | |
HM02260 | FBXO31 | prostate | MESH:D012878 | Skin Neoplasms | |
HM02260 | FBXO31 | prostate | MESH:D056487 | Drug-Induced Liver Injury, Chronic | liver |
HM02260 | FBXO31 | prostate | MESH:D006943 | Hyperglycemia | |
HM02260 | FBXO31 | prostate | MESH:D055371 | Acute Lung Injury | |
HM02260 | FBXO31 | prostate | MESH:D003876 | Dermatitis, Atopic | skin |
HM02260 | FBXO31 | prostate | MESH:D002779 | Cholestasis | liver |
HM02260 | FBXO31 | prostate | MESH:D004828 | Epilepsies, Partial | muscle |
HM02260 | FBXO31 | prostate | MESH:D005234 | Fatty Liver | |
HM02260 | FBXO31 | prostate | MESH:D005355 | Fibrosis | |
HM02260 | FBXO31 | prostate | MESH:D002386 | Cataract | pancreas |
HM02260 | FBXO31 | prostate | MESH:D002386 | Cataract | eye |
HM02260 | FBXO31 | prostate | MESH:D011471 | Prostatic Neoplasms | prostate |
HM02260 | FBXO31 | prostate | MESH:D001943 | Breast Neoplasms | breast |
HM02260 | FBXO31 | prostate | MESH:D006529 | Hepatomegaly | |
HM02260 | FBXO31 | prostate | MESH:D007251 | Influenza, Human | |
HM02260 | FBXO31 | prostate | MESH:D010018 | Osteomalacia | bone |
HM02260 | FBXO31 | prostate | MESH:D008114 | Liver Neoplasms, Experimental | |
HM02260 | FBXO31 | prostate | MESH:D011230 | Precancerous Conditions | |
HM02260 | FBXO31 | prostate | MESH:D014581 | Urticaria | skin |
HM02260 | FBXO31 | prostate | MESH:D006930 | Hyperalgesia | |